Vodafone Global Enterprise, the business within Vodafone which manages the communications needs of its largest multinational customers, has announced an agreement with Boston Scientific Corporation, a global leader in the design of medical devices, to develop mobile health monitoring solutions that are set to transform healthcare by providing doctors with real-time information about patients’ cardiac health and certain vital signs remotely.
Remote healthcare monitoring systems, powered by Vodafone’s machine-to-machine (M2M) technology, will allow patients to use mobile devices to send health information to their doctor without having to leave their home. This reduces pressure on hospital outpatient and inpatient services and significantly increases the speed with which doctors and consultants can respond to early signs of deterioration in their patients’ cardiac condition.
Vodafone Global Enterprise Chief Executive Nick Jeffery said: “The mobile internet has already transformed how people work, share their lives with friends and family and learn about the world around them. Wireless communications are now also set to change how we stay healthy and recover from illness. The new mobile technologies will empower both doctors and patients, enhancing quality of care while reducing costs and inefficiency.”
Boston Scientific Senior Vice President and President, Europe, Middle East and Africa, Michael Onuscheck, said: “With long patient lists and busy schedules, doctors are always looking for solutions that improve patient care while driving clinical efficiencies. Our collaboration with Vodafone allows us to use their mobile expertise and provide wireless remote patient monitoring services that appeal to both patients and healthcare providers.”